baber/WOPTO huggingface dataset:
Patent NZ-240932-A (NZ)
Title: Inhalation operated inhaler with piston and latching means. (51) a61m15/00;
Inventor: BLASNIK WILLIAM
IPC: A61M15/00
Filed: 1991-12-10
Abstract: Movement of the cover (B) relative to the housing (A) spring loads and latches a piston carrier (38) in the armed position. Inhalation causes a passageway door (14) to open, releasing the carrier latch (52) to permit the carrier to be moved toward the canister 18 by the spring 42. The piston 34 moves with the carrier 38, due to a fluid connection therebetween, applying a compression force on the spring loaded canister valve stem 32 and causing it to dispense the inhalant through an opening in the piston which functions as a nozzle. After the inhalant is dispensed, the carrier fluid vents permitting the spring of the canister valve stem to move the piston relative to the carrier, and thus release the force applied to the valve stem by the piston. The sensitivity of the toggle linkage between the door and the carrier latch is adjustable. The linkage can be manually tripped for testing purposes. <IMAGE>
Patent NZ-252766-A (NZ)
Title: Absorbent article; two fibre-based absorbent layers with superabsorbent material
Inventor: GUIDOTTI TED
IPC: A61F5/44
Filed: 1993-04-21
Abstract: PCT No. PCT/SE93/00348 Sec. 371 Date Oct. 14, 1994 Sec. 102(e) Date Oct. 14, 1994 PCT Filed Apr. 21, 1993 PCT Pub. No. WO93/21882 PCT Pub. Date Nov. 11, 1993An absorbent body intended to form the absorbent element of an absorbent article, such as a diaper, an incontinence guard or a sanitary napkin, includes a first fibre-based absorbent layer which lies proximal to the wearer in use, and a second, fibre-based absorbent layer which is intended to lie distal from the wearer in use, this second layer having a high liquid-dispersing ability. An absorbent body exhibiting particularly good absorption properties has been obtained by including in the first layer (16) a superabsorbent material (18) of high gel-strength and by mixing this superabsorbent essentially uniformly in the fibre material within at least one area of the layer, and by including between the fibre layers (17a, 17b) of the second layer (17) a layer (20) of superabsorbent material.
Patent NZ-274358-A (NZ)
Title: Multilayer film having an inner core layer comprising single site catalysed ethylene and alpha-olefin copolymer
Inventor: AHLGREN KELLY R
IPC: B32B27/32
Filed: 1994-09-19
Abstract: The present invention is directed to a heat-shrinkable, thermoplastic film or bag which contains at least one homogeneous ethylene alpha-olefin copolymer with at least some limited long chain branching. Oriented films made in accordance with the present invention exhibit improved processability as well as improved physical properties such as excellent optics and impact resistance. A homogeneous ethylene alpha-olefin with long chain branching may be present in a monolayer film either alone or in a blend or may be included in one or more layers of a multilayer film in accordance with the present invention.
Patent NZ-276157-A (NZ)
Title: Phase separation apparatus comprising an organically modified ceramic (ormocer) useful to coat filters and paper-making roller
Inventor: SAYERS IAN CHRISTISON
IPC: B01D69/10
Filed: 1994-11-16
Abstract: A method of coating an ormocer (organically modified ceramic) on a phase separation surface of a filter of a phase separation apparatus to facilitate phase separation.
Patent NZ-279820-A (NZ)
Title: Transdermal administration of sex steroids also containing dimethyl isosorbide as a solvent and penetration enhancer
Inventor: LIPP RALPH
IPC: A61K47/26
Filed: 1995-02-09
Abstract: PCT No. PCT/EP95/00483 Sec. 371 Date Nov. 8, 1996 Sec. 102(e) Date Nov. 8, 1996 PCT Filed Feb. 9, 1995 PCT Pub. No. WO95/22322 PCT Pub. Date Aug. 24, 1995Transdermal therapeutic systems that contain sex steroids and optionally penetration-enhancers and crystallization inhibitors are described, which are characterized in that they contain dimethyl isosorbide, with the exception of systems that contain active ingredient-containing, non-free-flowing gel phases or 3-keto-desogestrel.
Patent NZ-286586-A (NZ)
Title: Avermectin formulation with polymer carrier, as a parasiticide
Inventor: CHOI HOO-KYUN
IPC: A61K9/107
Filed: 1994-04-28
Abstract: There is disclosed a topical formulation containing glycols, glycerides, or their derivatives, an avermectin compound (active ingredient) and optionally a polymeric material which has been discovered to provide superior efficacy against endoparasites and ectoparasites when compared to conventional formulations and to maintain the concentration of the active compound in the milk of dairy animals below a safe concentration for human consumption. The formulation contains the avermectin active ingredient and at least 50 % of the glycol or glyceride or polymeric material.
Patent NZ-294878-A (NZ)
Title: Water soluble derivatives of epipodophyllotoxin and medicaments
Inventor: IMBERT THIERRY
IPC: A61K31/7048
Filed: 1995-10-20
Abstract: PCT No. PCT/FR95/01388 Sec. 371 Date Apr. 21, 1997 Sec. 102(e) Date Apr. 21, 1997 PCT Filed Oct. 20, 1995 PCT Pub. No. WO96/12727 PCT Pub. Date May 2, 1996Water-soluble derivatives of epipodophyllotoxin, process for their preparation and their use for the treatment of rheumatoid arthritis, complaints caused by human papilloma virus and cancer.
Patent NZ-297205-A (NZ)
Title: Air pressure control system for air mattress actuated by hand-held remote control
Inventor: SHAFER DAVID C
IPC: H04Q7/06
Filed: 1995-10-18
Abstract: An automatic controlling the firmness of a fluid supported mattress (14) of a bed assembly (10). The control system includes a motorised fluid pump, a control unit (44) for operating the pump to adjust the firmness of the air mattress (14), a hand held remote control unit (42) for actuating the control unit (44). The air control system provides for independent control of both bladders (30,32) in a two bladder air mattress (14) from a single unit (44), and allows a user to consistently set the firmness of each mattress air bladder (30,32) to a desired value. The air control system includes an air pump specially designed to minimise transmission of motor noise into the environment.
Patent NZ-331128-A (NZ)
Title: Reclosable dispenser package, reclosable outlet forming structure and method and apparatus for making same
Inventor: REDMOND SANFORD
IPC: B65D75/32
Filed: 1997-01-23
Abstract: An aperture forming structure includes a break away tip member (634) of thermoformable plastic.  The break away tip includes a hollow protrusion extending from a surface.  The intersection of the hollow protrusion and the surface is a fault line (636).  Rupturing of the fault line creates an aperture for dispensing the contents of the package . A cap (620) may be integrally formed with the aperture forming structure and detached for protecting the hollow protrusion or for closing the aperture.  The aperture forming structure can be made by heating a relatively stiff substantially flat thermoformable sheet of and then stretching the sheet to create a first and a second hollow protrusion in tiered configuration.  A rupture line is placed at the intersection of the first and the second protrusions.  The sheet may be attached to a pouch or containment member formed from a flexible sheet which contains any flowable substance.
Patent NZ-331709-A (NZ)
Title: Paper size comprising an alkyl ketene dimer and/or alkenyl succinic acid anhydride and a degraded liquid cationic starch and paper sizing process
Inventor: HASSLER THORD G G
IPC: D21H21/16
Filed: 1997-03-14
Abstract: PCT No. PCT/EP97/01308 Sec. 371 Date Aug. 19, 1998 Sec. 102(e) Date Aug. 19, 1998 PCT Filed Mar. 14, 1997 PCT Pub. No. WO97/35068 PCT Pub. Date Sep. 25, 1997Disclosed are a paper size consisting essentially of a) alkyl ketene dimer and/or alkenyl succinic acid anhydride; b) degraded, liquid cationic starch having a cationic charge density of 0.5 to 3.5 meqv/g, a degree of substitution of more than 0.1 and a viscosity of less than 10000 cps (30% by weight solution in water at 25 DEG  C.); and c) water, and a process for making paper products in which this paper size is added to the pulp. The invention allows the production of AKD and/or ASA sizes on-site in paper plants using simple mixing equipment.
Patent NZ-333343-A (NZ)
Title: Guarded snap hook with indexing member to maintain guard member in an open position
Inventor: KLEIN RICHARD T
IPC: A62B1/18
Filed: 1997-12-08
Abstract: A keeper-equipped snap hook (10) includes a guard member (62) which can be readily positioned by a user in either a closed position or an open position. In the closed position the keeper (40) is secured in a U-shaped channel provided by the guard member (62) to protect the keeper (40) from unintended or inadvertent actuation. In the open position the keeper (40) is exposed for ready activation to an open position by the user to either install the snap hook (10) on or remove the snap hook (10) from a D-ring (22) or the like. A cam actuator (84) in the hook body (30) and a camming surface (86) on the guard member (62) interact to bias the guard member (62) in the open and closed positions for ease of use during installation or removal of the snap hook (10).
Patent NZ-336843-A (NZ)
Title: Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
Inventor: YE QIANG
IPC: A61K47/24
Filed: 1998-01-29
Abstract: The rate of release of encapsulated active compound from a multivesicular liposomal (MVL) formulation is modified by selection of a neutral lipid component.  A family of MVL formulations containing different slow:fast release neutral lipid molar ratios display different release rates depending upon the molar ratio of the fast release neutral lipid to the slow release neutral lipid. Incubation in plasma or a plasma-like medium at in vivo temperatures so as to obtain a release rate curve for each member, allows selection from the family of a liposomal formulation with a desired rate of release in vivo.
Patent NZ-336984-A (NZ)
Title: Electrical cable with fire-resistant, moisture-resistant coating
Inventor: CAIMI LUIGI
IPC: H01B7/295
Filed: 1998-03-12
Abstract: Described is an electrical cable, in particular for low-tension power transmission or for telecommunications.  The cable comprises a coating which has fire-resistance properties and is capable of keeping its electrical insulation properties unchanged when the cable is in the presence of moisture. This cable comprises a metal conductor and a polymer coating consisting of a double layer in which both the layers which form the coating comprise a base polymer and an inorganic charge, and in which the innermost layer of the two also contains a predetermined amount of a coupling agent, in particular a polyolefin compound containing at least one unsaturation and at least one carboxyl group in the polymer chain.
Patent NZ-337072-A (NZ)
Title: use of an anti-CD40L compounds to inhibit the progression of nephritis, stabilize nephritis or reverse nephritis in a patient with an immune complex disease
Inventor: KALLED SUSAN L
IPC: C07K16/28
Filed: 1997-12-31
Abstract: An anti-CD40L compound is used in the manufacture of a medicament for treating a patient with immune complex disease wherein the medicament comprises an amount of the compound effective to: a) inhibit the progression of nephritis; b) stabilize nephritis, c) reverse nephritis in a patient with immune complex disease. The anti-CD40L compound can be antibody, complete Fab fragment or a F(ab')2 compound.
Patent NZ-504696-A (NZ)
Title: Polymeric coating composition for a plastics substrate comprising polymeric binder, inert filler, polyamide epichlorohydrin and an ionic insolubilising agent
Inventor: SHEPHERD JOHN VICTOR
IPC: B41M5/00
Filed: 2000-05-22
Abstract: The polymer coating composition for a plastics substrate comprises a polymeric binder, an inert filler, polyamide epichlorohydrin and an ionic insolubilising agent.  The ionic insolubilising agent is capable of reacting with the binder to render the binder insoluble in water. A synthetic paper comprising a plastics substrate and the polymer coating composition as described above is also described.
Patent NZ-506207-A (NZ)
Title: Disc brake with arc shaped grooves for wet disc application
Inventor: PARSONS FRANCIS EDWARD
IPC: F16D55/228
Filed: 1995-08-24
Abstract: Brake pad 10 has grooves 17 which are arc-shaped outwardly and angled outwardly with respect to radial lines from leading to trailing edges.
Patent NZ-507879-A (NZ)
Title: Antibodies to CD23 capable of binding to the CD23 (FCepsilonRII) type II molecule expressed on haematopoietic cells
Inventor: BONNEFOY HEAN-YVES MARCEL PAUL
IPC: C07K16/28
Filed: 1999-05-07
Abstract: Antibodies that bind to the CD23 (FCåRII) type II molecule are described. In particular, altered antibodies including antibodies which bind to the CD23 (FCåRII) type II molecule characterised by an affinity constant equal to or greater than 1x109 Ka Mol-1, the preparation of such antibodies, pharmaceutical compositions which contain such antibodies and their use in therapy particularly in the treatment of autoimmune and inflammatory disorders.
Patent NZ-513935-A (NZ)
Title: Immunogenic complexes and methods relating thereto
Inventor: COX JOHN COOPER
IPC: A61K47/42
Filed: 2000-02-17
Abstract: An immunogenic complex comprising a negatively-charged organic complex and a charged antigen, which antigen comprises a positive charge and which organic complex and antigen are electrostatically associated, and the use thereof for eliciting an immune response to the antigen.
Patent NZ-514992-A (NZ)
Title: Transparent multilayer polypropylene container with barrier protection
Inventor: CURIE KEVIN JAMES
IPC: B32B27/32
Filed: 2000-04-14
Abstract: A multilayer plastic container (10) comprises a layer of a polypropylene (24, 28) and a layer of EVOH (26) directly adjacent the layer of polypropylene, wherein at least one of the polypropylene and EVOH layers comprises an adhesive such as maleic anhydride concentrate mixed therein to adhere the layer of polypropylene to the layer of EVOH.
Patent NZ-518545-A (NZ)
Title: Aromatic di-keto derivatives, processes for their production and their use as a pharmaceutical
Inventor: VERTESY LASZLO
IPC: A61K31/40
Filed: 2000-08-19
Abstract: The present invention relates to new aromatic di-keto derivatives and to their pharmaceutically acceptable salts, esters, ethers and other obvious chemical equivalents. The derivatives are glucose-6-phosphate translocase inhibitors and can be used in the treatment of diabetes mellitus. The present invention further relates to a process for the production of the derivatives, to the use of the derivatives and their pharmaceutically acceptable salts, esters, ethers and other obvious chemical equivalents as pharmaceuticals, in particular to their use in the treatment of diabetes mellitus, and to pharmaceutical compositions comprising the derivatives, pharmaceutically acceptable salts, esters, ethers or other obvious chemical equivalents thereof.
Patent NZ-519984-A (NZ)
Title: High-throughput formation, identification, and analysis of diverse solid-forms
Inventor: LEVINSON DOUGLAS
IPC: G06F19/00
Filed: 2001-01-08
Abstract: The invention concerns arrays of solid-forms of substances, such as compounds and rapid-screening methods therefor to identify solid-forms, particularly of pharmaceuticals, with enhanced properties. Such properties include improved bioavailability, solubility, stability, delivery, and processing and manufacturing characteristics. The invention relates to a practical and cost-effective method to rapidly screen hundreds to thousands of samples in parallel. The invention further provides methods for determining the conditions and/or ranges of conditions required to produce crystals with desired compositions, particle sizes, habits, or polymorphic forms. In a further aspect, the invention provides high-throughput methods to identify sets of conditions and/or combinations of components compatible with particular solid-forms, for example, conditions and/or components that are compatible with advantageous polymorphs of a particular pharmaceutical.
Patent NZ-521522-A (NZ)
Title: 4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamides useful as antiviral agents
Inventor: VAILLANCOURT VALERIE A
IPC: A61K31/444
Filed: 2001-03-15
Abstract: A 4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamide derivative or a pharmaceutically acceptable salt thereof has the formula III wherein: A is Cl, Br, CN, NO2 or F; R1 is R5, NR7R8 or SO2R9; R2 is aryl, het, SOmR6, O-alkyl substituted by OH, S-alkyl substituted by OH, or partially unsaturated optionally substituted alkyl provided that when R1 is R5 which is (CH2CH2O)iR10, then R2 may additionally be H, halo, (C=O)R6, (C=O)OR9, cyano, OR10, Ohet, NR7R8, SR10, Shet, NHCOR12, NHSO2R12, or R2 together with R3 or R4 form an optionally substituted carbocyclic or het; R3 and R4 are independently H, halo, aryl, S(O)mR6, (C=O)R6, (C=O)OR9, cyano, het wherein the het is bound via a carbon atom, OR10, Ohet, NR7R8, SR10, Shet, NHCOR12, NHSO2R12, partially unsaturated optionally substituted alkyl or R4 together with R3 form an optionally substituted carbocyclic or het; R5 is (CH2CH2O)iR10, het, wherein the het is bound via a carbon atom, aryl or partially unsaturated optionally substituted alkyl or cycloalkyl; R6 to R10, R11 and R12 are as defined in the specification; i is 2 to 4 and m is 0 to 2; aryl is an optionally substituted phenyl radical or an ortho-fused bicyclic carbocyclic radical wherein at least one ring is aromatic and het is an optionally substituted 4 to 7 membered optionally saturated heterocyclic ring having 1, 2, or 3 heteroatoms selected from oxygen, sulphur, and nitrogen, which is optionally fused to a benzene ring or any bicyclic heterocycle group. The compounds are useful for treating or preventing viral infections such as herpes virus infections or for inhibiting viral DNA polymerase.
Patent NZ-522888-A (NZ)
Title: Mutations in the gamma aminobutyric acid type A receptor subunit ( GABA A ) associated with epilepsy
Inventor: WALLACE ROBYN HEATHER
IPC: C12Q1/68
Filed: 2001-06-20
Abstract: An isolated mammalian DNA molecule encoding a mutant gamma -aminobutyric acid type A (GABAA) receptor subunit, wherein a mutation event selected from the group consisting of point mutations, deletions, insertions and rearrangements has occurred and said mutation event disrupts the functioning of an assembled GABA receptor, or an otherwise functional fragment or homologue thereof. This mutation event creates a phenotype of epilepsy and/or anxiety and/or manic depression and/or phobic obsessive symptoms and/or Alzheimer's disease and/or schizophrenia and/or migraine and/or obesity. A method of diagnosing these disorders is disclosed.
Patent NZ-523707-A (NZ)
Title: Azabicyclic compounds, preparations thereof and use as medicines, in particular as antibacterial agents
Inventor: LAMPILAS MAXIME
IPC: A61P31/04
Filed: 2001-07-24
Abstract: Heterocyclic compounds of general formula (I), and their addition salts or base with an acid; a method for preparing these compounds; and their use as medicines, in particular as antibacterial agents are disclosed, wherein R1, R2, R3, A, X and n are as defined in the specification.
Patent NZ-524678-A (NZ)
Title: 28kDa protein p28-9 from Ehrlichia Canis and uses thereof
Inventor: WALKER DAVID H
IPC: C12N15/117
Filed: 2001-09-12
Abstract: An isolated DNA sequence encodes a 30kDa protein of Ehrlichia canis which is immunoreactive with anti-Ehrlichia canis serum and comprises an amino acid sequence of SEQ ID NO:46. The protein can be post-translationally modified to a 28-kilodalton protein. The DNA sequence preferably comprises the sequence of SEQ ID NO: 45. Vectors, non-human host cells, antibodies and methods of producing the protein are described. The 28kDa antigen comprising the amino acid of SEQ ID NO:46 is used in the manufacture of a medicament for inhibiting Ehrlichia canis infection in a subject prior to exposure or suspected of being exposed to or infected with Ehrlichia canis.
Patent NZ-526037-A (NZ)
Title: ABCA-1 elevating compounds against coronary artery disease or atherosclerosis and pharmaceutical compositions
Inventor: CAMPBELL MICHAEL
IPC: A61K31/167
Filed: 2001-12-06
Abstract: Compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans are disclosed, wherein these compounds are useful for treating coronary artery disease.
Patent NZ-532818-A (NZ)
Title: A roadway freezing point sensor including an active cooler, a cold thermal link, a sample well and a temperature sensor
Inventor: LEONHARDT PATRICK A
IPC: G01N25/04
Filed: 2002-11-01
Abstract: A roadway freezing point sensor comprises: a sensor module configured to be embedded in a roadway, the sensor module comprises an active cooler (30), a cold thermal link (32) in thermal contact with the active cooler (30), a sample well (20) adjacent the thermal link, and a temperature sensor adjacent the sample well; the sample well comprises a first surface (42) in thermal contact with the temperature sensor and a second surface (44) in thermal contact with the thermal link (32); the thermal link (32) having a thermal conductivity greater than 1 W/m-K closely adjacent the second surface (44) of the sample well (20). A roadway freezing point sensor further comprises a thermally insulating cover (14) disposed over a portion of the cold thermal link (32) spaced from the sample well (20).
Patent NZ-533800-A (NZ)
Title: Electrical hair buffing apparatus for hair removal
Inventor: DAVIS ALICE
IPC: A45D26/00
Filed: 2002-12-20
Abstract: A hair buffing apparatus is electrically powered so that an abrasive surface is controlled for continuous movement in differing directions across the hairy skin. This movement might be effected by quickly oscillating rotary motion of a disc, or two counter-rotating disc surfaces 128, 134, or other suitable motion. This movement acts to gently knot and abrade hairs from below the surface of the skin.
Patent NZ-536294-A (NZ)
Title: Polymeric microemulsions of amphiphilic diblock copolymers
Inventor: ARIEN ALBERTINA MARIA EDUARDA
IPC: A61K47/34
Filed: 2003-04-24
Abstract: A diblock copolymer of formula A-B is disclose, wherein polymer block A represents a linear pharmaceutically acceptable hydrophilic polymer and polymer block B represents a polymer comprising monomers selected from glycolic acid, propiolactone, g-butyrolactone, d-valerolactone, g-valerolactone, e-caprolactone, trimethylene carbonate, p-dioxanone, tetramethylene carbonate, e-lactone, 1, 5-dioxepan-2-one or mixtures thereof characterized in that the diblock copolymer is liquid at a temperature below 50 °C. These amphiphilic diblock copolymers can be used to form microemulsions and aqueous micellar solutions. Diverse drugs with a hydrophobic nature can be loaded into the core of the micelles, allowing them to be solubilized in an aqueous medium, wherein the solubility and bioavailability of poorly water soluble drugs can be enhanced.
Patent NZ-536615-A (NZ)
Title: An apparatus and method for manufacturing sleepers
Inventor: HADLEY LAWRENCE MARCUS
Filed: 2002-05-31
Abstract: An apparatus for manufacturing sleepers, the apparatus comprising: a mould for location of a settable material, said mould including a base having at least a pair of holes for location of two cast-in components; an engagement mechanism to engage said cast-in components that are located within the holes; and a spacer located between the cast-in components to space the cast-in components at a predetermine distance from each other; wherein the engagement mechanism exerts a longitudinal force and a normal force with respect to said base on said cast-in components to hold the cast-in components in a predetermined position within the mould.